Artemisinins as Anticancer Drugs: Novel Therapeutic Approaches, Molecular Mechanisms, and Clinical Trials
Artemisinin and its derivatives have shown broad-spectrum antitumor activities in vitro and in vivo. Furthermore, outcomes from a limited number of clinical trials provide encouraging evidence for their excellent antitumor activities. However, some problems such as poor solubility, toxicity and cont...
Saved in:
Main Authors: | Cangcang Xu (Author), Huihui Zhang (Author), Lingli Mu (Author), Xiaoping Yang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel dihydroartemisinin derivative Mito-DHA5 induces apoptosis associated with mitochondrial pathway in bladder cancer cells
by: Linfan Xiao, et al.
Published: (2022) -
Molecular Hybridization as a Strategy for Developing Artemisinin-Derived Anticancer Candidates
by: Elena Marchesi, et al.
Published: (2023) -
Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics
by: David Dolivo, et al.
Published: (2021) -
Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?
by: Zhaowu Ma, et al.
Published: (2021) -
Anti-Melanoma Activities of Artemisone and Prenylated Amino-Artemisinins in Combination With Known Anticancer Drugs
by: Ho Ning Wong, et al.
Published: (2020)